speb/financial-data huggingface dataset:
Financial ratios for BOH — quarterly report dated 2025-12-31
Total revenue: 189511000
Net income: 60935000
Capital expenditures: 8223000
Operating cash flow: 79848000
Depreciation & amortization: 7497000
Net tangible assets: 1802240000
Owner earnings: 60209000
Return on net tangible assets (%): 3.340787020596591
Buffett classification: The Gruesome
Stock price: 67.15
P/E ratio: 12.921444626812756
Shares outstanding: 39621017
Book value: 1851212000
P/B ratio: 1.4371942768035213
Market cap (USD): 2660551291.55
Debt to equity: 0.35143354731926973
Effective tax rate (%): 21.502827624409033
COGS to revenue (%): 0
SG&A to revenue (%): 37.60045591021102
Free cash flow (dilution-adjusted): 67062000
Buyback yield (%): 0.04758412303573543
Retained earnings: 2205707000
Receivables turnover: 1.1006435051282946
Capitalized R&D asset: 0
FCF margin (%): 35.386864087045076
Revenue growth (%): 4.757772078008225
Rule of 40 score: 40.1446361650533
Financial ratios for BRNL.NS — annual report dated 2022-03-31
Total revenue: 28537056.573915336
Gross profit: 18324330.73981274
Operating income: 7527245.153633127
Net income: -49626440.72266913
Capital expenditures: 3728023.20981142
Operating cash flow: 2894514.044573388
Depreciation & amortization: 5657114.598443888
Net tangible assets: -168336660.95212978
Owner earnings: -47697349.33403666
Capex to operating income (%): 49.52705981699081
Buffett classification: The Good
Stock price: 0.3784781748648292
Shares outstanding: 83950000
Book value: 79367031.51786894
P/B ratio: 0.4003330119855735
Market cap (USD): 31773242.779902413
Debt to equity: 2.479718204267511
Current ratio: 0.8760056287656148
Quick ratio: 0.8760056287656148
Interest coverage ratio: 0.31826583645628714
COGS to revenue (%): 35.78759360710548
SG&A to revenue (%): 4.0422095551453
Free cash flow (dilution-adjusted): -833509.1652380325
Buyback yield (%): 0
Retained earnings: -87920677.83199261
Receivables turnover: 1.5685759289287335
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.5770921878065227
FCF margin (%): -2.920795853907064
Rule of 40 score: -2.920795853907064
Financial ratios for BRNL.NS — annual report dated 2023-03-31
Total revenue: 39749001.2180268
Gross profit: 29443751.5225335
Operating income: 5510974.421437272
Net income: -24999427.527405605
Capital expenditures: 1027624.8477466505
Operating cash flow: 31600073.081607796
Depreciation & amortization: 6914116.930572473
Net tangible assets: -179534092.57003656
Owner earnings: -19112935.444579784
Capex to operating income (%): 18.646881098726713
Buffett classification: The Great
Stock price: 0.3197320341047503
Shares outstanding: 83950000
Book value: 48683081.60779536
P/B ratio: 0.5513517915594687
Market cap (USD): 26841504.26309379
Debt to equity: 3.5344594947910646
Current ratio: 0.7965639799694398
Quick ratio: 0.7965639799694398
Interest coverage ratio: 0.2505523824712844
COGS to revenue (%): 25.925807893808685
SG&A to revenue (%): 2.4211610431229094
Free cash flow (dilution-adjusted): 30572448.23386115
Buyback yield (%): 0
Retained earnings: -106693556.63824604
Receivables turnover: 5.540010423404108
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.275153642301985
FCF margin (%): 76.91375203660729
Revenue growth (%): 39.28907179011548
Rule of 40 score: 116.20282382672278
Financial ratios for BRNL.NS — annual report dated 2024-03-31
Total revenue: 45535687.732342005
Gross profit: 34533493.22460727
Operating income: 13730663.14905864
Net income: -13430986.928888356
Capital expenditures: 12485537.834272694
Operating cash flow: 31710312.987168726
Depreciation & amortization: 9823575.968341528
Net tangible assets: -192848674.9010673
Owner earnings: -16092948.794819523
Capex to operating income (%): 90.9317903930131
Buffett classification: The Gruesome
Stock price: 0.6693857965451055
Shares outstanding: 83950000
Book value: 34323971.6992445
P/B ratio: 1.6371921673970649
Market cap (USD): 56194937.61996161
Debt to equity: 4.639946322437111
Current ratio: 0.4850986029964335
Quick ratio: 0.4850986029964335
Interest coverage ratio: 0.6154514322817983
COGS to revenue (%): 24.161696145681276
SG&A to revenue (%): 2.627684825297237
Free cash flow (dilution-adjusted): 19224775.15289603
Buyback yield (%): 0
Retained earnings: -118407650.79745772
Receivables turnover: 782.4481763857407
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.322176468034032
FCF margin (%): 42.21913868062986
Revenue growth (%): 14.558067717411848
Rule of 40 score: 56.77720639804171
Financial ratios for BRNL.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: -197380602.00668895
Buffett classification: The Gruesome
Stock price: 0.561753463927377
Shares outstanding: 83950000
Book value: 31616137.1237458
P/B ratio: 1.491618128809406
Market cap (USD): 47159203.2967033
Debt to equity: 4.947348278346434
Current ratio: 0.4912847377330598
Quick ratio: 0.4912847377330598
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRNL.NS — quarterly report dated 2024-12-31
Total revenue: 5565683.6461126
Gross profit: 5565683.6461126
Operating income: -2836146.404009791
Net income: 19766569.53024828
Capital expenditures: 0
Depreciation & amortization: 2056311.924466721
Owner earnings: 21822881.454715002
Buffett classification: The Gruesome
Stock price: 0.5308310991957104
P/E ratio: 0.563619179206663
Shares outstanding: 83950000
Market cap (USD): 44563270.77747989
Effective tax rate (%): 0.3221665121561737
Interest coverage ratio: -18.37295174809333
COGS to revenue (%): 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRNL.NS — annual report dated 2025-03-31
Total revenue: 32065267.71101239
Gross profit: 25529880.75754033
Operating income: -2051367.781155015
Net income: 16497077.390694411
Capital expenditures: 6097591.769932195
Operating cash flow: 8346808.510638298
Depreciation & amortization: 8667734.393266307
Net tangible assets: -28904746.317512274
Owner earnings: 19067220.014028523
Return on net tangible assets (%): -65.96570613206326
Buffett classification: The Gruesome
Stock price: 0.3380791224180184
P/E ratio: 1.7204103281349747
Shares outstanding: 83950000
Book value: 49344973.1119944
P/B ratio: 0.5751698812881475
Market cap (USD): 28381742.326992646
Debt to equity: 1.0289312714687076
Current ratio: 0.7968229550298868
Quick ratio: 0.7968229550298868
Effective tax rate (%): -1.564714975960749
Interest coverage ratio: -0.32410378029341746
COGS to revenue (%): 20.381513768642474
SG&A to revenue (%): 5.363446880139475
Free cash flow (dilution-adjusted): 2249216.7407061025
Buyback yield (%): 0
Retained earnings: -98864250.64297403
Receivables turnover: 292.1046858359957
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.178266714219088
FCF margin (%): 7.014495437796202
Revenue growth (%): -29.582116120675533
Rule of 40 score: -22.56762068287933
Financial ratios for BRNL.NS — quarterly report dated 2025-03-31
Total revenue: 5525157.820902501
Gross profit: 5525157.820902501
Operating income: -1482709.843348141
Net income: -672387.1872808043
Capital expenditures: 0
Depreciation & amortization: 2096188.917465513
Net tangible assets: -28904746.317512274
Owner earnings: 1423801.7301847087
Buffett classification: The Gruesome
Stock price: 0.3380791224180184
Shares outstanding: 83950000
Book value: 49344973.1119944
P/B ratio: 0.5751698812881475
Market cap (USD): 28381742.326992646
Debt to equity: 1.0289312714687076
Current ratio: 0.7968229550298868
Quick ratio: 0.7968229550298868
Interest coverage ratio: -10.750211900322089
COGS to revenue (%): 0
Buyback yield (%): 0
Retained earnings: -98864250.64297403
Receivables turnover: 50.33248136315228
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.574431229875202
Revenue growth (%): -0.7281374182739387
Rule of 40 score: -0.7281374182739387
Financial ratios for BRNL.NS — quarterly report dated 2025-06-30
Total revenue: 5411397.144863094
Gross profit: 5411397.144863094
Operating income: 1050889.3049379827
Net income: 1562146.0332319215
Capital expenditures: 0
Depreciation & amortization: 2233021.296512989
Owner earnings: 3795167.3297449104
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.24022934706295346
P/E ratio: 0.9763232515790184
Shares outstanding: 83950000
Market cap (USD): 20167253.685934942
Effective tax rate (%): 3.05360695975484
Interest coverage ratio: 29936.333333333332
COGS to revenue (%): 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -2.058957947029736
Rule of 40 score: -2.058957947029736
Financial ratios for BRNL.NS — quarterly report dated 2025-09-30
Total revenue: 1928297.6324689966
Gross profit: 1928297.6324689966
Operating income: -6117981.961668545
Net income: 1371454.3404735061
Capital expenditures: 0
Depreciation & amortization: 800541.1499436302
Net tangible assets: -15636268.320180383
Owner earnings: 2171995.4904171363
Return on net tangible assets (%): -13.890753509351903
Buffett classification: The Gruesome
Stock price: 0.2577226606538895
P/E ratio: 0.9822058643023475
Shares outstanding: 83950000
Book value: 63321634.72378807
P/B ratio: 0.3416812824916866
Market cap (USD): 21635817.361894023
Debt to equity: 0.7732550966068791
Current ratio: 1.4438419864128442
Quick ratio: 1.4438419864128442
Effective tax rate (%): 0.9897122021096497
Interest coverage ratio: -180888.3333333333
COGS to revenue (%): 0
Buyback yield (%): 0
Receivables turnover: 89.4093047569263
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.544130117183109
Revenue growth (%): -64.36599309109143
Rule of 40 score: -64.36599309109143
Financial ratios for BRNL.NS — quarterly report dated 2025-12-31
Total revenue: 4684014.70424418
Gross profit: 4684014.70424418
Operating income: 1885150.941294419
Net income: 2808900.5235602097
Capital expenditures: 0
Depreciation & amortization: 1936537.8188704469
Owner earnings: 4745438.342430657
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.2519772752589952
P/E ratio: 4.172192867456602
Shares outstanding: 83950000
Market cap (USD): 21153492.257992648
Effective tax rate (%): -1.0888433645099604
Interest coverage ratio: 56410
COGS to revenue (%): 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 142.9093219518585
Rule of 40 score: 142.9093219518585
Financial ratios for BRX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 20.53
Shares outstanding: 306836617
Market cap (USD): 6299355747.01
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRX — annual report dated 2022-12-31
Total revenue: 1218074000
Gross profit: 906283000
Operating income: 444327000
Net income: 354193000
Capital expenditures: 0
Operating cash flow: 566382000
Depreciation & amortization: 344731000
Net tangible assets: 2865010000
Owner earnings: 698924000
Return on net tangible assets (%): 24.395167905173107
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 19.14
P/E ratio: 16.580939909540845
Shares outstanding: 306836617
Book value: 2865010000
P/B ratio: 2.0498542236781025
Market cap (USD): 5872852849.38
Debt to equity: 1.7575858373967281
Current ratio: 0.3338710101419025
Quick ratio: 0.3338710101419025
Interest coverage ratio: 2.30906785430319
COGS to revenue (%): 26.595018036671007
SG&A to revenue (%): 9.623799539272655
Free cash flow (dilution-adjusted): 542975000
Buyback yield (%): 0
Retained earnings: -446336000
Receivables turnover: 4.6113664412862585
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.936291946813094
FCF margin (%): 44.576519981544635
Rule of 40 score: 44.576519981544635
Financial ratios for BRX — annual report dated 2023-12-31
Total revenue: 1245036000
Gross profit: 925046000
Operating income: 445641000
Net income: 305087000
Capital expenditures: 0
Operating cash flow: 588794000
Depreciation & amortization: 362277000
Net tangible assets: 2850301000
Owner earnings: 667364000
Return on net tangible assets (%): 23.413807875027935
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 20.61
P/E ratio: 20.72819450310895
Shares outstanding: 306836617
Book value: 2850301000
P/B ratio: 2.218678896148161
Market cap (USD): 6323902676.37
Debt to equity: 1.7308785984357442
Current ratio: 0.2995267448571935
Quick ratio: 0.2995267448571935
Interest coverage ratio: 2.33646511091421
COGS to revenue (%): 26.726456102474145
SG&A to revenue (%): 9.407599458971468
Free cash flow (dilution-adjusted): 568017000
Buyback yield (%): 0
Retained earnings: -460595000
Receivables turnover: 4.4660963142319074
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.127839502777626
FCF margin (%): 45.62253621582026
Revenue growth (%): 2.2134944182373153
Rule of 40 score: 47.83603063405758
Financial ratios for BRX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 25.58
Shares outstanding: 306836617
Market cap (USD): 7848880662.86
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 25.81
Shares outstanding: 306836617
Market cap (USD): 7919453084.7699995
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRX — annual report dated 2024-12-31
Total revenue: 1285054000
Gross profit: 967938000
Operating income: 470179000
Net income: 339276000
Capital expenditures: 0
Operating cash flow: 624687000
Depreciation & amortization: 381396000
Net tangible assets: 2983678000
Owner earnings: 720672000
Return on net tangible assets (%): 24.15381284441552
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 25.81
P/E ratio: 23.342214258509298
Shares outstanding: 306836617
Book value: 2983922000
P/B ratio: 2.6540415884765083
Market cap (USD): 7919453084.7699995
Debt to equity: 1.7895075675570609
Current ratio: 0.6339877445945371
Quick ratio: 0.6339877445945371
Interest coverage ratio: 2.1768150967156497
COGS to revenue (%): 25.54624163653823
SG&A to revenue (%): 9.055105855473776
Free cash flow (dilution-adjusted): 606750000
Buyback yield (%): 0
Retained earnings: -458638000
Receivables turnover: 4.557785683124843
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.006184270094662
FCF margin (%): 47.21591466195195
Revenue growth (%): 3.2142042479092976
Rule of 40 score: 50.43011890986125
Financial ratios for BRX — quarterly report dated 2025-03-31
Total revenue: 337512000
Gross profit: 253408000
Operating income: 119638000
Net income: 69737000
Capital expenditures: 0
Operating cash flow: 130088000
Depreciation & amortization: 105597000
Net tangible assets: 2953777000
Owner earnings: 175334000
Return on net tangible assets (%): 5.935925427004137
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 24.87
P/E ratio: 27.356448745966993
Shares outstanding: 306836617
Book value: 2954029000
P/B ratio: 2.5832605789550476
Market cap (USD): 7631026664.79
Debt to equity: 1.7278476277653334
Current ratio: 0.3935435077750212
Quick ratio: 0.3935435077750212
Interest coverage ratio: 2.2120775090599807
COGS to revenue (%): 25.88944985659769
SG&A to revenue (%): 8.347258764132832
Free cash flow (dilution-adjusted): 125975000
Buyback yield (%): 0.0010221429360206082
Retained earnings: -477401000
Receivables turnover: 1.2314270911624987
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5820752270568477
FCF margin (%): 37.32459882907867
Rule of 40 score: 37.32459882907867
Financial ratios for BRX — quarterly report dated 2025-06-30
Total revenue: 339492000
Gross profit: 256056000
Operating income: 123686000
Net income: 85146000
Capital expenditures: 0
Operating cash flow: 181454000
Depreciation & amortization: 106553000
Net tangible assets: 2952905000
Owner earnings: 191699000
Return on net tangible assets (%): 6.491878336756517
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 24.66
P/E ratio: 48.8535925519263
Shares outstanding: 306836617
Book value: 2953164000
P/B ratio: 2.562198027342877
Market cap (USD): 7566590975.22
Debt to equity: 1.7259193868000557
Current ratio: 0.4007029742395932
Quick ratio: 0.4007029742395932
Interest coverage ratio: 2.2732636144755465
COGS to revenue (%): 24.57672051182355
SG&A to revenue (%): 8.569568649629446
Free cash flow (dilution-adjusted): 176657000
Buyback yield (%): 0.000859039430211967
Retained earnings: -480851000
Receivables turnover: 1.1909618076384723
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6356938480899228
FCF margin (%): 52.035688617110274
Revenue growth (%): 0.5866458081490435
Rule of 40 score: 52.62233442525932
Financial ratios for BRX — quarterly report dated 2025-09-30
Total revenue: 340843000
Gross profit: 256497000
Operating income: 126491000
Net income: 94242000
Capital expenditures: 0
Operating cash flow: 168267000
Depreciation & amortization: 103234000
Net tangible assets: 2962731000
Owner earnings: 197476000
Return on net tangible assets (%): 6.665336812555712
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 26.51
P/E ratio: 32.65123418633217
Shares outstanding: 306836617
Book value: 2962997000
P/B ratio: 2.745274030540699
Market cap (USD): 8134238716.67
Debt to equity: 1.8540079520836505
Current ratio: 0.657872651920425
Quick ratio: 0.657872651920425
Interest coverage ratio: 2.23166901905434
COGS to revenue (%): 24.746290814245857
SG&A to revenue (%): 7.854642753408461
Free cash flow (dilution-adjusted): 164183000
Buyback yield (%): 0.0012047839191043474
Retained earnings: -475197000
Receivables turnover: 1.1132148187824769
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.587625928717427
FCF margin (%): 48.169685162963596
Revenue growth (%): 0.39794752159108315
Rule of 40 score: 48.56763268455468
Financial ratios for BRX — quarterly report dated 2025-12-31
Total revenue: 353750000
Gross profit: 265120000
Operating income: 133667000
Net income: 137130000
Capital expenditures: 0
Operating cash flow: 172201000
Depreciation & amortization: 102822000
Net tangible assets: 3009814000
Owner earnings: 239952000
Return on net tangible assets (%): 7.972319884218759
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 25.38
P/E ratio: 20.16158584215091
Shares outstanding: 306836617
Book value: 3010056000
P/B ratio: 2.5871656007263653
Market cap (USD): 7787513339.46
Debt to equity: 1.8254653734016908
Current ratio: 0.628263879200249
Quick ratio: 0.628263879200249
Interest coverage ratio: 2.2459002621143895
COGS to revenue (%): 29.825583038869258
SG&A to revenue (%): 8.09356890459364
Free cash flow (dilution-adjusted): 167579000
Buyback yield (%): 0.0026709424553540873
Retained earnings: -432822000
Receivables turnover: 1.1225597217638548
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6677128315459946
FCF margin (%): 47.372155477031804
Revenue growth (%): 3.786787465196586
Rule of 40 score: 51.15894294222839
Financial ratios for BRX — annual report dated 2025-12-31
Total revenue: 1371597000
Gross profit: 1031081000
Operating income: 503482000
Net income: 386255000
Capital expenditures: 0
Operating cash flow: 652010000
Depreciation & amortization: 414930000
Net tangible assets: 3009814000
Owner earnings: 801185000
Return on net tangible assets (%): 26.61908676084303
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 25.38
P/E ratio: 20.16158584215091
Shares outstanding: 306836617
Book value: 3010056000
P/B ratio: 2.5871656007263653
Market cap (USD): 7787513339.46
Debt to equity: 1.8254653734016908
Current ratio: 0.628263879200249
Quick ratio: 0.628263879200249
Interest coverage ratio: 2.24079505449755
COGS to revenue (%): 26.05677906848732
SG&A to revenue (%): 8.214439080867047
Free cash flow (dilution-adjusted): 634394000
Buyback yield (%): 0.005765640204105698
Retained earnings: -432822000
Receivables turnover: 4.352507552486609
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.281755346139589
FCF margin (%): 46.252215483119315
Revenue growth (%): 6.734580803608253
Rule of 40 score: 52.98679628672757
Financial ratios for CCM — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 20
Shares outstanding: 2815458
Market cap (USD): 56309160
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCM — annual report dated 2022-12-31
Total revenue: 67828304.59770115
Gross profit: -21897844.827586208
Operating income: -75437931.03448276
Net income: -70353591.95402299
Capital expenditures: 54330172.4137931
Operating cash flow: -31134195.40229885
Depreciation & amortization: 19082471.264367815
Net tangible assets: -459862787.3563218
Owner earnings: -105601293.10344827
Buffett classification: The Gruesome
Stock price: 16.4
Shares outstanding: 2815458
Book value: 289605890.8045976
P/B ratio: 0.15943567678032525
Market cap (USD): 46173511.199999996
Debt to equity: 1.6073563111184102
Current ratio: 0.6776450274518477
Quick ratio: 0.6019829902001006
Interest coverage ratio: -4.362421795159402
COGS to revenue (%): 132.28422847580416
SG&A to revenue (%): 78.93472573794973
Free cash flow (dilution-adjusted): -85571982.75862068
Buyback yield (%): 0
Retained earnings: -541225718.3908046
Inventory turnover: 7.361277774503447
Receivables turnover: 3.6238687044699125
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.75103333580414
FCF margin (%): -126.15969581749049
Rule of 40 score: -126.15969581749049
Financial ratios for CCM — annual report dated 2023-12-31
Total revenue: 75583966.24472573
Gross profit: -10774683.544303797
Operating income: -65117440.22503516
Net income: -41864697.609001406
Capital expenditures: 16229535.864978902
Operating cash flow: -38884810.12658228
Depreciation & amortization: 18066666.666666664
Net tangible assets: -480804219.4092827
Owner earnings: -40027566.80731364
Buffett classification: The Gruesome
Stock price: 11
Shares outstanding: 2815458
Book value: 245708438.81856537
P/B ratio: 0.12604385160278814
Market cap (USD): 30970038
Debt to equity: 1.8865057381651953
Current ratio: 0.3162908156938066
Quick ratio: 0.29561482714408266
Interest coverage ratio: -2.7946387073019094
COGS to revenue (%): 114.25525025958223
SG&A to revenue (%): 71.89720172236055
Free cash flow (dilution-adjusted): -55750210.97046413
Buyback yield (%): 0
Retained earnings: -571672151.8987341
Inventory turnover: 15.218231838798426
Receivables turnover: 7.311989768150648
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.285300919014007
FCF margin (%): -73.75930867395358
Revenue growth (%): 11.43425549705903
Rule of 40 score: -62.325053176894556
Financial ratios for CCM — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -483969863.01369864
Buffett classification: The Gruesome
Stock price: 5.38
Shares outstanding: 2815458
Book value: 221609452.05479455
P/B ratio: 0.06835071293012697
Market cap (USD): 15147164.04
Debt to equity: 2.429753317727286
Current ratio: 0.46296830411860607
Quick ratio: 0.44723399149789095
Buyback yield (%): 0
Retained earnings: -599018082.1917808
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCM — annual report dated 2024-12-31
Total revenue: 52596712.32876713
Gross profit: -10844109.589041095
Operating income: -72898630.1369863
Net income: -42225068.49315069
Capital expenditures: 54886849.31506849
Operating cash flow: -54486164.38356165
Depreciation & amortization: 17911917.80821918
Net tangible assets: -483969863.01369864
Owner earnings: -79200000
Buffett classification: The Gruesome
Stock price: 5.38
Shares outstanding: 2815458
Book value: 221609452.05479455
P/B ratio: 0.06835071293012697
Market cap (USD): 15147164.04
Debt to equity: 2.429753317727286
Current ratio: 0.46296830411860607
Quick ratio: 0.44723399149789095
Interest coverage ratio: -2.7544656028240313
COGS to revenue (%): 120.61746658471282
SG&A to revenue (%): 117.98174790861454
Free cash flow (dilution-adjusted): -110764794.52054794
Buyback yield (%): 0
Retained earnings: -599018082.1917808
Inventory turnover: 13.848808349032625
Receivables turnover: 7.5038305190744214
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.566098308792828
FCF margin (%): -210.59261998770688
Revenue growth (%): -30.412870689440254
Rule of 40 score: -241.00549067714712
Financial ratios for CCM — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -430352301.2552301
Buffett classification: The Gruesome
Stock price: 5.73
Shares outstanding: 2815458
Book value: 240170153.4170153
P/B ratio: 0.06717143704358836
Market cap (USD): 16132574.340000002
Debt to equity: 2.2197930337626746
Current ratio: 0.4177686798984311
Quick ratio: 0.41219029815474567
Buyback yield (%): 0
Retained earnings: -613663458.8563459
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CI — annual report dated 2021-12-31
Gross profit: 192618000000
Operating income: 15570000000
Capital expenditures: 0
Depreciation & amortization: 35964000000
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 212.69
Shares outstanding: 264532404
Market cap (USD): 56263397006.76
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CI — annual report dated 2022-12-31
Total revenue: 179363000000
Gross profit: 22345000000
Operating income: 7295000000
Net income: 6782000000
Capital expenditures: 1295000000
Operating cash flow: 8656000000
Depreciation & amortization: 2937000000
Net tangible assets: -33628000000
Owner earnings: 8424000000
Return on net tangible assets (%): -25.050553110503156
Capex to operating income (%): 17.751884852638796
Buffett classification: The Great
Stock price: 311.97
P/E ratio: 12.16841257385432
Shares outstanding: 264532404
Book value: 44754000000
P/B ratio: 1.8439954881324574
Market cap (USD): 82526174075.88
Debt to equity: 0.6947535415828753
Current ratio: 0.7306731352334749
Quick ratio: 0.614796846573681
Effective tax rate (%): 19.23305942598547
Interest coverage ratio: 5.940553745928339
COGS to revenue (%): 87.5420237172661
SG&A to revenue (%): 7.344881608804492
Free cash flow (dilution-adjusted): 7361000000
Buyback yield (%): 9.217681644862905
Retained earnings: 37940000000
Inventory turnover: 32.869583420556836
Receivables turnover: 10.376800694243563
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.105980907851158
FCF margin (%): 4.10396793095566
Rule of 40 score: 4.10396793095566
Financial ratios for CI — annual report dated 2023-12-31
Total revenue: 194099000000
Gross profit: 24011000000
Operating income: 7370000000
Net income: 5372000000
Capital expenditures: 1573000000
Operating cash flow: 11813000000
Depreciation & amortization: 3035000000
Net tangible assets: -28899000000
Owner earnings: 6834000000
Return on net tangible assets (%): -23.647877089172635
Capex to operating income (%): 21.343283582089555
Buffett classification: The Great
Stock price: 287.09
P/E ratio: 14.137119855614294
Shares outstanding: 264532404
Book value: 46351000000
P/B ratio: 1.6384675166524993
Market cap (USD): 75944607864.36
Debt to equity: 0.6672995188884814
Current ratio: 0.7667090894162082
Quick ratio: 0.6508334017571229
Effective tax rate (%): 2.5575911481951747
Interest coverage ratio: 5.096818810511756
COGS to revenue (%): 87.6295086528009
SG&A to revenue (%): 7.636309306075765
Free cash flow (dilution-adjusted): 10240000000
Buyback yield (%): 3.0074551231857196
Retained earnings: 41652000000
Inventory turnover: 30.130735163861825
Receivables turnover: 10.841096961572832
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.083473497044548
FCF margin (%): 5.275658298084998
Revenue growth (%): 8.215741262133216
Rule of 40 score: 13.491399560218214
Financial ratios for CI — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 336.19
Shares outstanding: 264532404
Market cap (USD): 88933148900.76
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CI — annual report dated 2024-12-31
Total revenue: 246148000000
Gross profit: 24991000000
Operating income: 8444000000
Net income: 3778000000
Capital expenditures: 1406000000
Operating cash flow: 10363000000
Depreciation & amortization: 2775000000
Net tangible assets: -32754000000
Owner earnings: 5147000000
Return on net tangible assets (%): -15.714111253587348
Capex to operating income (%): 16.650876361913785
Buffett classification: The Great
Stock price: 269.1
P/E ratio: 18.842157203917417
Shares outstanding: 264532404
Book value: 41243000000
P/B ratio: 1.7260061081007687
Market cap (USD): 71185669916.40001
Debt to equity: 0.7752103387241471
Current ratio: 0.8428913917107919
Quick ratio: 0.7274702909674192
Effective tax rate (%): 28.297589675460237
Interest coverage ratio: 5.884320557491289
COGS to revenue (%): 89.8471651201716
SG&A to revenue (%): 6.030518224807839
Free cash flow (dilution-adjusted): 8957000000
Buyback yield (%): 9.88120222547696
Retained earnings: 43519000000
Inventory turnover: 33.047967722653915
Receivables turnover: 10.160069344120197
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.624951482094339
FCF margin (%): 3.6388676731072365
Revenue growth (%): 26.815697144240826
Rule of 40 score: 30.45456481734806
Financial ratios for CI — quarterly report dated 2024-12-31
Gross profit: 6185000000
Operating income: 1896000000
Capital expenditures: 0
Depreciation & amortization: 424000000
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 269.1
Shares outstanding: 264532404
Market cap (USD): 71185669916.40001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CI — quarterly report dated 2025-03-31
Total revenue: 65264000000
Gross profit: 6368000000
Operating income: 1733000000
Net income: 1409000000
Capital expenditures: 327000000
Operating cash flow: 1920000000
Depreciation & amortization: 674000000
Net tangible assets: -33191000000
Owner earnings: 1756000000
Return on net tangible assets (%): -5.290590822813413
Capex to operating income (%): 18.869013271783036
Buffett classification: The Great
Stock price: 322.18
P/E ratio: 15.121903818438609
Shares outstanding: 264532404
Book value: 40414000000
P/B ratio: 2.108849654098085
Market cap (USD): 85227049920.72
Debt to equity: 0.753402286336418
Current ratio: 0.781325679433133
Quick ratio: 0.6884743026280384
Effective tax rate (%): 14.502427184466018
Interest coverage ratio: 4.787292817679558
COGS to revenue (%): 90.242706545722
SG&A to revenue (%): 6.455319931355724
Free cash flow (dilution-adjusted): 1593000000
Buyback yield (%): 1.7693912923218313
Retained earnings: 44434000000
Inventory turnover: 11.378670788253478
Receivables turnover: 2.417632894980552
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8258826504272334
FCF margin (%): 2.440855601863202
Rule of 40 score: 2.440855601863202
Financial ratios for CI — quarterly report dated 2025-06-30
Total revenue: 66942000000
Gross profit: 5925000000
Operating income: 2070000000
Net income: 1632000000
Capital expenditures: 285000000
Operating cash flow: -1886000000
Depreciation & amortization: 682000000
Net tangible assets: -32832000000
Owner earnings: 2029000000
Return on net tangible assets (%): -6.179946393762183
Capex to operating income (%): 13.768115942028986
Buffett classification: The Great
Stock price: 325.29
P/E ratio: 28.296529331522528
Shares outstanding: 264532404
Book value: 40430000000
P/B ratio: 2.128363732306703
Market cap (USD): 86049745697.16
Debt to equity: 0.7610190452634182
Current ratio: 0.7876679758361366
Quick ratio: 0.6825763046196657
Effective tax rate (%): 19.247897080653143
Interest coverage ratio: 6.142433234421365
COGS to revenue (%): 91.14905440530609
SG&A to revenue (%): 5.128320038242061
Free cash flow (dilution-adjusted): -2171000000
Buyback yield (%): 1.292275753973205
Retained earnings: 45564000000
Inventory turnover: 10.225741578682754
Receivables turnover: 2.141938373916104
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.1818871742980015
FCF margin (%): -3.2431059723342592
Revenue growth (%): 2.571095856827654
Rule of 40 score: -0.6720101155066054
Financial ratios for CI — quarterly report dated 2025-09-30
Total revenue: 69515000000
Gross profit: 6143000000
Operating income: 2345000000
Net income: 1973000000
Capital expenditures: 278000000
Operating cash flow: 3418000000
Depreciation & amortization: 697000000
Net tangible assets: -32094000000
Owner earnings: 2392000000
Return on net tangible assets (%): -7.453106499657257
Capex to operating income (%): 11.855010660980811
Buffett classification: The Great
Stock price: 285.07
P/E ratio: 15.039938653426406
Shares outstanding: 264532404
Book value: 42014000000
P/B ratio: 1.7948839055619554
Market cap (USD): 75410252408.28
Debt to equity: 0.8102061217689341
Current ratio: 0.827856801232884
Quick ratio: 0.7280923954439976
Effective tax rate (%): 14.030501089324618
Interest coverage ratio: 6.75792507204611
COGS to revenue (%): 91.16305833273394
SG&A to revenue (%): 4.836366251888082
Free cash flow (dilution-adjusted): 3140000000
Buyback yield (%): 0
Retained earnings: 47028000000
Inventory turnover: 11.252130681818182
Receivables turnover: 2.1853877833317616
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.311118995525595
FCF margin (%): 4.517010717111415
Revenue growth (%): 3.8436258253413405
Rule of 40 score: 8.360636542452756
Financial ratios for CI — annual report dated 2025-12-31
Total revenue: 273854000000
Gross profit: 24514000000
Operating income: 8154000000
Net income: 6288000000
Capital expenditures: 1212000000
Operating cash flow: 9601000000
Depreciation & amortization: 2775000000
Net tangible assets: -31771000000
Owner earnings: 7851000000
Return on net tangible assets (%): -24.711214629693746
Capex to operating income (%): 14.863870493009564
Buffett classification: The Great
Stock price: 273.72
P/E ratio: 11.515236899312978
Shares outstanding: 264532404
Book value: 41874000000
P/B ratio: 1.7291830162602095
Market cap (USD): 72407809622.88
Debt to equity: 0.7513731671204088
Current ratio: 0.8486386709736964
Quick ratio: 0.7183983529161194
Effective tax rate (%): 19.18776506875723
Interest coverage ratio: 5.791193181818182
COGS to revenue (%): 91.04851490210112
SG&A to revenue (%): 5.337515610507789
Free cash flow (dilution-adjusted): 8389000000
Buyback yield (%): 5.000841786071384
Retained earnings: 47865000000
Inventory turnover: 33.97928590896702
Receivables turnover: 9.49102377486657
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.027407779320122
FCF margin (%): 3.063311107378384
Revenue growth (%): 11.255829825958367
Rule of 40 score: 14.319140933336751
Financial ratios for CI — quarterly report dated 2025-12-31
Total revenue: 72133000000
Gross profit: 6078000000
Operating income: 2006000000
Net income: 1274000000
Capital expenditures: 322000000
Operating cash flow: 6149000000
Depreciation & amortization: 722000000
Net tangible assets: -31771000000
Owner earnings: 1674000000
Return on net tangible assets (%): -5.268955966132636
Capex to operating income (%): 16.051844466600198
Buffett classification: The Great
Stock price: 273.72
P/E ratio: 11.515236899312978
Shares outstanding: 264532404
Book value: 41874000000
P/B ratio: 1.7291830162602095
Market cap (USD): 72407809622.88
Debt to equity: 0.7513731671204088
Current ratio: 0.8486386709736964
Quick ratio: 0.7183983529161194
Effective tax rate (%): 29.884424876169508
Interest coverage ratio: 5.541436464088398
COGS to revenue (%): 91.57389821579582
SG&A to revenue (%): 5.003257870877407
Free cash flow (dilution-adjusted): 5827000000
Buyback yield (%): 1.3824475636170823
Retained earnings: 47865000000
Inventory turnover: 9.00177159989098
Receivables turnover: 2.499930685520205
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9748565127932505
FCF margin (%): 8.07813344793645
Revenue growth (%): 3.7660936488527654
Rule of 40 score: 11.844227096789215
Financial ratios for CNM — annual report dated 2022-01-31
Capital expenditures: 1000000
Buffett classification: The Gruesome
Stock price: 24.05
Shares outstanding: 187192831
Market cap (USD): 4501987585.55
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNM — annual report dated 2023-01-31
Total revenue: 6651000000
Gross profit: 1795000000
Operating income: 775000000
Net income: 581000000
Capital expenditures: 1000000
Operating cash flow: 401000000
Depreciation & amortization: 148000000
Net tangible assets: -583000000
Owner earnings: 728000000
Return on net tangible assets (%): -124.8713550600343
Capex to operating income (%): 0.12903225806451613
Buffett classification: The Great
Stock price: 22.07
P/E ratio: 7.1107500519277105
Shares outstanding: 187192831
Book value: 2410000000
P/B ratio: 1.71425136106639
Market cap (USD): 4131345780.17
Debt to equity: 0.6780082987551868
Current ratio: 3.0454545454545454
Quick ratio: 1.603305785123967
Effective tax rate (%): 18.053596614950635
Interest coverage ratio: 11.742424242424242
COGS to revenue (%): 73.01157720643512
SG&A to revenue (%): 13.231093068711472
Free cash flow (dilution-adjusted): 365000000
Buyback yield (%): 0
Retained earnings: 458000000
Inventory turnover: 4.638013371537727
Receivables turnover: 6.964397905759163
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.527372699019843
FCF margin (%): 5.487896556908735
Rule of 40 score: 5.487896556908735
Financial ratios for CNM — annual report dated 2024-01-31
Total revenue: 6702000000
Gross profit: 1818000000
Operating income: 740000000
Net income: 531000000
Capital expenditures: 39000000
Operating cash flow: 1069000000
Depreciation & amortization: 154000000
Net tangible assets: -894000000
Owner earnings: 646000000
Return on net tangible assets (%): -72.25950782997764
Capex to operating income (%): 5.27027027027027
Buffett classification: The Great
Stock price: 41.31
P/E ratio: 14.562967699830509
Shares outstanding: 187192831
Book value: 1524000000
P/B ratio: 5.07410488753937
Market cap (USD): 7732935848.610001
Debt to equity: 1.3589238845144358
Current ratio: 2.2906976744186047
Quick ratio: 1.301033591731266
Effective tax rate (%): 19.423368740515933
Interest coverage ratio: 9.135802469135802
COGS to revenue (%): 72.87376902417189
SG&A to revenue (%): 13.89137570874366
Free cash flow (dilution-adjusted): 1020000000
Buyback yield (%): 0
Retained earnings: 189000000
Inventory turnover: 6.375979112271541
Receivables turnover: 6.8879753340185
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.229336437718278
FCF margin (%): 15.21933751119069
Revenue growth (%): 0.7668019846639603
Rule of 40 score: 15.98613949585465
Financial ratios for CNM — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 44.28
Shares outstanding: 187192831
Market cap (USD): 8288898556.68
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNM — quarterly report dated 2025-01-31
Total revenue: 1698000000
Gross profit: 451000000
Operating income: 124000000
Net income: 67000000
Capital expenditures: 11000000
Operating cash flow: 235000000
Depreciation & amortization: 50000000
Net tangible assets: -1135000000
Owner earnings: 106000000
Return on net tangible assets (%): -9.33920704845815
Capex to operating income (%): 8.870967741935484
Buffett classification: The Great
Stock price: 56.44
P/E ratio: 39.42225142402985
Shares outstanding: 187192831
Book value: 1774000000
P/B ratio: 5.955559967102593
Market cap (USD): 10565163381.64
Debt to equity: 1.4126268320180384
Current ratio: 2.338337182448037
Quick ratio: 1.289838337182448
Effective tax rate (%): 23.863636363636363
Interest coverage ratio: 3.4444444444444446
COGS to revenue (%): 73.43934040047114
SG&A to revenue (%): 16.431095406360424
Free cash flow (dilution-adjusted): 221000000
Buyback yield (%): 0
Retained earnings: 449000000
Inventory turnover: 1.3733480176211454
Receivables turnover: 1.5928705440900564
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.478017585931255
FCF margin (%): 13.015312131919906
Rule of 40 score: 13.015312131919906
Financial ratios for CNM — annual report dated 2025-01-31
Total revenue: 7441000000
Gross profit: 1980000000
Operating income: 719000000
Net income: 434000000
Capital expenditures: 35000000
Operating cash flow: 621000000
Depreciation & amortization: 194000000
Net tangible assets: -1135000000
Owner earnings: 593000000
Return on net tangible assets (%): -52.24669603524229
Capex to operating income (%): 4.867872044506258
Buffett classification: The Great
Stock price: 56.44
P/E ratio: 24.343694427741934
Shares outstanding: 187192831
Book value: 1774000000
P/B ratio: 5.955559967102593
Market cap (USD): 10565163381.64
Debt to equity: 1.4126268320180384
Current ratio: 2.338337182448037
Quick ratio: 1.289838337182448
Effective tax rate (%): 24.783362218370883
Interest coverage ratio: 5.063380281690141
COGS to revenue (%): 73.39067329659991
SG&A to revenue (%): 14.487300094073378
Free cash flow (dilution-adjusted): 572000000
Buyback yield (%): 0
Retained earnings: 449000000
Inventory turnover: 6.01431718061674
Receivables turnover: 6.980300187617261
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.368505195843326
FCF margin (%): 7.68713882542669
Revenue growth (%): 11.026559236048941
Rule of 40 score: 18.713698061475633
Financial ratios for CNM — quarterly report dated 2025-04-30
Total revenue: 1911000000
Gross profit: 510000000
Operating income: 171000000
Net income: 105000000
Capital expenditures: 13000000
Operating cash flow: 77000000
Depreciation & amortization: 48000000
Net tangible assets: -1056000000
Owner earnings: 140000000
Return on net tangible assets (%): -13.257575757575758
Capex to operating income (%): 7.602339181286549
Buffett classification: The Great
Stock price: 52.68
P/E ratio: 23.479329374000002
Shares outstanding: 187192831
Book value: 1821000000
P/B ratio: 5.41533132184514
Market cap (USD): 9861318337.08
Debt to equity: 1.3887973640856672
Current ratio: 1.9614767255216694
Quick ratio: 1.1035313001605136
Effective tax rate (%): 25.53191489361702
Interest coverage ratio: 5.7
COGS to revenue (%): 73.31240188383046
SG&A to revenue (%): 15.332286760858189
Free cash flow (dilution-adjusted): 59000000
Buyback yield (%): 0
Retained earnings: 515000000
Inventory turnover: 1.3105706267539756
Receivables turnover: 1.44882486732373
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.3982511923688397
FCF margin (%): 3.087388801674516
Revenue growth (%): 12.54416961130742
Rule of 40 score: 15.631558412981937
Financial ratios for CNM — quarterly report dated 2025-07-31
Total revenue: 2093000000
Gross profit: 560000000
Operating income: 213000000
Net income: 141000000
Capital expenditures: 10000000
Operating cash flow: 34000000
Depreciation & amortization: 48000000
Net tangible assets: -879000000
Owner earnings: 179000000
Return on net tangible assets (%): -20.36405005688282
Capex to operating income (%): 4.694835680751173
Buffett classification: The Great
Stock price: 63.64
P/E ratio: 38.06054876945687
Shares outstanding: 187192831
Book value: 1962000000
P/B ratio: 6.071840858735984
Market cap (USD): 11912951764.84
Debt to equity: 1.291539245667686
Current ratio: 2.2470904207699194
Quick ratio: 1.3017009847806624
Effective tax rate (%): 22.52747252747253
Interest coverage ratio: 6.870967741935484
COGS to revenue (%): 73.24414715719062
SG&A to revenue (%): 14.429049211657908
Free cash flow (dilution-adjusted): 19000000
Buyback yield (%): 0
Retained earnings: 642000000
Inventory turnover: 1.4517045454545454
Receivables turnover: 1.5423728813559323
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.104837155521295
FCF margin (%): 0.9077878643096035
Revenue growth (%): 9.523809523809524
Rule of 40 score: 10.431597388119128
Financial ratios for CNM — quarterly report dated 2025-10-31
Total revenue: 2062000000
Gross profit: 561000000
Operating income: 220000000
Net income: 143000000
Capital expenditures: 8000000
Operating cash flow: 271000000
Depreciation & amortization: 48000000
Net tangible assets: -788000000
Owner earnings: 183000000
Return on net tangible assets (%): -23.223350253807105
Capex to operating income (%): 3.6363636363636362
Buffett classification: The Great
Stock price: 52.18
P/E ratio: 21.420442810482456
Shares outstanding: 187192831
Book value: 2055000000
P/B ratio: 4.7531493535669105
Market cap (USD): 9767721921.58
Debt to equity: 1.1844282238442823
Current ratio: 2.2646793134598013
Quick ratio: 1.3468834688346885
Effective tax rate (%): 24.736842105263158
Interest coverage ratio: 7.333333333333333
COGS to revenue (%): 72.79340446168769
SG&A to revenue (%): 14.306498545101842
Free cash flow (dilution-adjusted): 259000000
Buyback yield (%): 0
Retained earnings: 736000000
Inventory turnover: 1.4773622047244095
Receivables turnover: 1.5365126676602086
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.236472174080493
FCF margin (%): 12.560620756547042
Revenue growth (%): -1.4811275680840899
Rule of 40 score: 11.079493188462951
Financial ratios for CNM — quarterly report dated 2026-01-31
Total revenue: 1581000000
Gross profit: 428000000
Operating income: 118000000
Net income: 73000000
Capital expenditures: 15000000
Operating cash flow: 268000000
Depreciation & amortization: 48000000
Net tangible assets: -746000000
Owner earnings: 106000000
Return on net tangible assets (%): -14.209115281501342
Capex to operating income (%): 12.711864406779661
Buffett classification: The Great
Stock price: 53.36
P/E ratio: 21.62036680121212
Shares outstanding: 187192831
Book value: 2074000000
P/B ratio: 4.816108708852459
Market cap (USD): 9988609462.16
Debt to equity: 1.1750241080038573
Current ratio: 2.6338672768878717
Quick ratio: 1.505720823798627
Effective tax rate (%): 22.340425531914892
Interest coverage ratio: 4.068965517241379
COGS to revenue (%): 72.92852624920936
SG&A to revenue (%): 16.698292220113853
Free cash flow (dilution-adjusted): 250000000
Buyback yield (%): 0
Retained earnings: 755000000
Inventory turnover: 1.169371196754564
Receivables turnover: 1.508587786259542
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.264440606409518
FCF margin (%): 15.812776723592664
Revenue growth (%): -23.32686711930165
Rule of 40 score: -7.514090395708985
Financial ratios for CNM — annual report dated 2026-01-31
Total revenue: 7647000000
Gross profit: 2059000000
Operating income: 722000000
Net income: 462000000
Capital expenditures: 46000000
Operating cash flow: 650000000
Depreciation & amortization: 192000000
Net tangible assets: -746000000
Owner earnings: 608000000
Return on net tangible assets (%): -81.50134048257372
Capex to operating income (%): 6.3711911357340725
Buffett classification: The Great
Stock price: 53.36
P/E ratio: 21.62036680121212
Shares outstanding: 187192831
Book value: 2074000000
P/B ratio: 4.816108708852459
Market cap (USD): 9988609462.16
Debt to equity: 1.1750241080038573
Current ratio: 2.6338672768878717
Quick ratio: 1.505720823798627
Effective tax rate (%): 23.88797364085667
Interest coverage ratio: 6.016666666666667
COGS to revenue (%): 73.07440826467896
SG&A to revenue (%): 15.090885314502419
Free cash flow (dilution-adjusted): 587000000
Buyback yield (%): 0
Retained earnings: 755000000
Inventory turnover: 5.667342799188641
Receivables turnover: 7.29675572519084
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.855306083285356
FCF margin (%): 7.676212893945338
Revenue growth (%): 2.768445101464857
Rule of 40 score: 10.444657995410195
Financial ratios for CPLE3.SA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.7999999999999999
Shares outstanding: 2969578102
Market cap (USD): 2375662481.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0